4//SEC Filing
Busque Philippe 4
Accession 0001991396-25-000002
CIK 0001831915other
Filed
Nov 19, 7:00 PM ET
Accepted
Nov 20, 7:07 PM ET
Size
20.6 KB
Accession
0001991396-25-000002
Insider Transaction Report
Form 4
Busque Philippe
SVP, GLOBAL SALES AND SERVICES
Transactions
- Exercise/Conversion
Common Stock
2025-11-18+3,625→ 29,829 total - Exercise/Conversion
Restricted Stock Units
2025-11-18−3,625→ 48,338 total→ Common Stock (3,625 underlying) - Exercise/Conversion
Common Stock
2025-11-18+1,536→ 24,952 total - Tax Payment
Common Stock
2025-11-18$5.53/sh−393$2,173→ 24,559 total - Tax Payment
Common Stock
2025-11-18$5.53/sh−565$3,124→ 26,204 total - Exercise/Conversion
Restricted Stock Units
2025-11-18−2,210→ 20,628 total→ Common Stock (2,210 underlying) - Exercise/Conversion
Common Stock
2025-11-18+2,210→ 26,769 total - Tax Payment
Common Stock
2025-11-18$5.53/sh−927$5,126→ 28,902 total - Exercise/Conversion
Restricted Stock Units
2025-11-18−1,536→ 8,714 total→ Common Stock (1,536 underlying)
Footnotes (5)
- [F1]Each Restricted Stock Unit (the "RSU Award") represents a contingent right to receive one share of the Issuer's common stock.
- [F2]Represents the number of shares withheld by and surrendered to the Issuer on November 18, 2025, to satisfy tax withholding obligations that arose in connection with the vesting of the RSU Award.
- [F3]The shares subject to the RSU Award shall vest over four years with 13/48 of the total shares underlying the RSU Award vesting on May 18, 2024; 3/48 of the total shares underlying the RSU Award vesting on August 18, 2024 and each August 18 thereafter; 3/48 of the total shares underlying the RSU Award vesting on November 18, 2024 and each November 18 thereafter; 4/48 of the total shares underlying the RSU Award vesting on March 10, 2025 and each March 10 thereafter; and 2/48 of the total shares underlying the RSU Award vesting on May 18, 2025 and each May 18 thereafter.
- [F4]The shares subject to the RSU Award shall vest over 4 years with 2/48 of the total shares underlying the RSU Award vesting on May 18, 2024 and each May 18 thereafter; 3/48 of the total shares underlying the RSU Award vesting on August 18, 2024 and each August 18 thereafter; 3/48 of the total shares underlying the RSU Award vesting on November 18, 2024 and each November 18 thereafter; and 4/48 of the total shares underlying the RSU Award vesting on March 10, 2025 and each March 10 thereafter.
- [F5]The shares subject to the RSU Award shall vest over 4 years with 2/48 of the total shares underlying the RSU Award vesting on May 18, 2025 and each May 18 thereafter; 3/48 of the total shares underlying the RSU Award vesting on August 18, 2025 and each August 18 thereafter; 3/48 of the total shares underlying the RSU Award vesting on November 18, 2025 and each November 18 thereafter; and 4/48 of the total shares underlying the RSU Award vesting on March 10, 2026 and each March 10 thereafter, until fully vested.
Documents
Issuer
Cytek Biosciences, Inc.
CIK 0001831915
Entity typeother
Related Parties
1- filerCIK 0001991396
Filing Metadata
- Form type
- 4
- Filed
- Nov 19, 7:00 PM ET
- Accepted
- Nov 20, 7:07 PM ET
- Size
- 20.6 KB